BUDENOFALK Rectal foam Ref.[6671] Active ingredients: Budesonide

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2017  Publisher: Dr. Falk Pharma GmbH, Leinenweberstr. 5, 79108, Freiburg, Germany

Therapeutic indications

For the treatment of active ulcerative colitis that is limited to the rectum and the sigmoid colon.

Posology and method of administration

Posology

Adults aged >18 years

One actuation of 2 mg budesonide daily.

Paediatric population

Budenofalk 2mg rectal foam should not be used in children due to insufficient experience in this age group.

Method of administration

Budenofalk 2mg rectal foam can be applied in the morning or evening.

The canister is first fitted with an applicator and then shaken for about 15 seconds before the applicator is inserted into the rectum as far as comfortable. Note that the dose is only sufficiently accurate when the pump dome is held downwards as vertically as possible. To administer a dose of Budenofalk 2mg rectal foam, the pump dome is fully pushed down and very slowly released. Following the activation the applicator should be held in position for 10-15 seconds before being withdrawn from the rectum.

The best results are obtained when the intestine is evacuated prior to administration of Budenofalk 2mg rectal foam.

Duration of treatment

The attending physician determines the duration of use. An acute episode generally subsides after 6 to 8 weeks. Budenofalk 2mg rectal foam should not be used after this period of time.

Overdose

To date, no cases of overdose with budesonide are known.

Shelf life

Shelf life: 3 years.

After first opening: 4 weeks.

Special precautions for storage

Do not store above 25°C.

Do not refrigerate or freeze.

This is a pressurised container, containing inflammable propellant.

Do not expose to temperature higher than 50°C, protected from direct sunlight. Do not pierce or burn even when empty.

Nature and contents of container

Aluminium pressurised container with metering valve together with 14 PVC applicators coated with white soft paraffin and liquid paraffin for administration of the foam and 14 plastic bags for hygienic disposal of the applicators.

Pack sizes:

Original pack with 1 pressurised container, contains at least 14 doses of 1.2 g rectal foam each.

Original pack with 2 pressurised containers, contains at least 2 × 14 doses of 1.2 g rectal foam each.

Hospital pack with 1 pressurised container, contains at least 14 doses of 1.2 g rectal foam each.

Not all pack sizes may be marketed.

Special precautions for disposal and other handling

No special requirements.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.